Discontinuation of secondary anti-Leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy

被引:41
作者
Berenguer, J [1 ]
Cosín, J [1 ]
Miralles, P [1 ]
López, JC [1 ]
Padilla, B [1 ]
机构
[1] Hosp Gen Gregorio Maranon, Serv Microbiol & Enfermedades Infecciosas, E-28007 Madrid, Spain
关键词
D O I
10.1097/00002030-200012220-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2946 / 2948
页数:3
相关论文
共 10 条
[1]   Leishmania and human immunodeficiency virus coinfection: The first 10 years [J].
Alvar, J ;
Canavate, C ;
GutierrezSolar, B ;
Jimenez, M ;
Laguna, F ;
LopezVelez, R ;
Molina, R ;
Moreno, J .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :298-+
[2]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[3]   VISCERAL LEISHMANIASIS IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) [J].
BERENGUER, J ;
MORENO, S ;
CERCENADO, E ;
DEQUIROS, JCLB ;
DELAFUENTE, AG ;
BOUZA, E .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) :129-132
[4]   Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1 [J].
Komanduri, KV ;
Viswanathan, MN ;
Wieder, ED ;
Schmidt, DK ;
Bredt, BM ;
Jacobson, MA ;
McCune, JM .
NATURE MEDICINE, 1998, 4 (08) :953-956
[5]   Drug therapy: Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. [J].
Kovacs, JA ;
Masur, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (19) :1416-1429
[6]   Treatment of visceral leishmaniasis in HIV-infected patients:: a randomized trial comparing meglumine antimoniate with amphotericin B [J].
Laguna, F ;
López-Vélez, R ;
Pulido, F ;
Salas, A ;
Torre-Cisneros, J ;
Torres, E ;
Medrano, FJ ;
Sanz, J ;
Picó, G ;
Gómez-Rodrigo, J ;
Pasquau, J ;
Alvar, J .
AIDS, 1999, 13 (09) :1063-1069
[7]   Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: Results from the EuroSIDA study [J].
Miller, V ;
Mocroft, A ;
Reiss, P ;
Katlama, C ;
Papadopoulos, AI ;
Katzenstein, T ;
van Lunzen, J ;
Antunes, F ;
Phillips, AN ;
Lundgren, JD .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (07) :570-577
[8]  
MONTALBAN C, 1989, REV INFECT DIS, V11, P655
[9]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[10]   Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients [J].
Ribera, E ;
Ocana, I ;
deOtero, J ;
Cortes, E ;
Gasser, I ;
Pahissa, A .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (05) :496-501